Hangzhou Tian-Mu-Shan Stock Hits Day High with 9.99% Surge

Hangzhou Tian-Mu-Shan Pharmaceutical Enterprise Co., Ltd. has experienced a significant surge in its stock price, gaining 9.99% on July 13, 2026. The stock reached an intraday high of CNY 21.13, marking a notable performance in the pharmaceuticals and biotechnology sector. Over the past week, the company's stock has risen by 14.28%, significantly outperforming the China Shanghai Composite, which declined by 3.15%. In the last month, Hangzhou Tian-Mu-Shan has shown a robust increase of 28.29%, while the broader index has faced a decrease of 2.92%. Year-to-date, the stock has appreciated by 22.07%, contrasting with the China Shanghai Composite's decline of 1.39%. Longer-term performance metrics reveal that Hangzhou Tian-Mu-Shan has increased by 56.52% over the past year and an impressive 153.66% over the last three years. However, the company faces challenges, including a high debt-to-equity ratio of 2.08 and a relatively low average return on capital employed of 5.37%. Despite these factors, the recent stock activity highlights the company's current market momentum.